Visilizumab |
カタログ番号GC72365 |
Visilizumab(抗ヒトCD 3 E組換え抗体)は、ヒト化低Fc受容体結合の抗CD 3モノクローナルIgG 2抗体である。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 219716-33-3
Sample solution is provided at 25 µL, 10mM.
Visilizumab induces dose- and time-dependent apoptosis of lamina propria T cells. Visilizumab-induces apoptosis of lamina propria T cells is dependent on caspase 3 and 8, but not caspase 9 activation and does not involve the Fas/FasL pathway[1].
References:
[1]. Qi T Yu, et al. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin Immunol. 2008 Jun;127(3):322-9.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *